G01N 2800/20
Dermatological disorders
G01N2800/20 (Dermatological disorders) appears on 237 US grants and 547 published applications in this corpus.
Search patents in G01N- Granted patents
- 237
- Published applications
- 547
- Assignees
- 276
- Inventors
- 1,092
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 1 |
| 2002 | 2 | 4 |
| 2003 | 2 | 9 |
| 2004 | 1 | 10 |
| 2005 | 0 | 8 |
| 2006 | 5 | 15 |
| 2007 | 7 | 21 |
| 2008 | 7 | 21 |
| 2009 | 2 | 22 |
| 2010 | 12 | 28 |
| 2011 | 14 | 44 |
| 2012 | 3 | 28 |
| 2013 | 15 | 26 |
| 2014 | 13 | 24 |
| 2015 | 22 | 41 |
| 2016 | 11 | 26 |
| 2017 | 22 | 24 |
| 2018 | 17 | 19 |
| 2019 | 11 | 32 |
| 2020 | 14 | 26 |
| 2021 | 11 | 20 |
| 2022 | 8 | 19 |
| 2023 | 12 | 22 |
| 2024 | 6 | 22 |
| 2025 | 7 | 20 |
| 2026 | 7 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Melanogenesis detection method using FAM86A11 Aug 2026US 12,704,520 B2Research & Business Foundation Sungkyunkwan University
- Biomarkers associated with anti-IL-36R antibody treatment in generalized pustular psoriasis12 May 2026US 12,624,397 B2Boehringer Ingelheim International GmbH
- Pharmaceutical composition for prevention, amelioration, or treatment of skin disease24 Mar 2026US 12,582,680 B2Keio University
- Method for identifying molecular markers of children's skin24 Mar 2026US 12,584,905 B2Laboratoires Expanscience
- Use of melanocortin-1 receptor agonist27 Jan 2026US 12,533,350 B2Tanabe Pharma Corporation
- Wrinkle determination of a human individual1 Oct 2026US 2026/0297652 A1Beiersdorf AG
- Collagen Type VI Alpha-6 Assay3 Sep 2026US 2026/0259223 A1Nordic Bioscience A/S
- Biomarker of skin aging, method for determining skin aging, and method for screening substance for improving skin aging3 Sep 2026US 2026/0259224 A1Rohto Pharmaceutical Co., Ltd.
- Method for the selection of an ecobiological compound capable of increasing the skin tolerance threshold13 Aug 2026US 2026/0235581 A1
- Biomarkers for assessing the effect of drugs in pathological disorders30 Jul 2026US 2026/0219281 A1DermAb. io
Most cited
By later US patents
- Use of AIM3 acting as a tumor suppressor88US 7,902,165 B2Seoul National University Industry Foundation · 2011
- Anti-CD6 monoclonal antibodies and their uses62US 6,572,857 B1Centro de Inmunologia Molecular (CIM) · 2003
- Enzyme treatment of foodstuffs for Celiac Sprue47US 7,303,871 B2The Board of Trustees of the Leland Stanford Junior University · 2007
- Drug therapy for celiac sprue36US 7,202,216 B2The Board of Trustees of the Leland Stanford Junior University · 2007
- Peptides for diagnostic and therapeutic methods for celiac sprue34US 7,462,688 B2The Board of Trustees of the Leland Stanford Junior University · 2008